NCT07476326
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07476326
Title Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Biocon Biologics UK PLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries TUR | ROU | ESP | BRA

Facility Status City State Zip Country Details
Biocon Investigational Site NOT_YET_RECRUITING Bento Gonçalves Brazil Details
Biocon Investigational Site NOT_YET_RECRUITING Ijuí Brazil Details
Biocon Investigational Site NOT_YET_RECRUITING Pará Brazil Details
Biocon Investigational Site NOT_YET_RECRUITING Porto Alegre Brazil Details
Biocon Investigational Site NOT_YET_RECRUITING Rio de Janeiro Brazil Details
Biocon Investigational Site 1 NOT_YET_RECRUITING Santa Catarina Brazil Details
Biocon Investigational Site 2 NOT_YET_RECRUITING Santa Catarina Brazil Details
Biocon Investigational Site NOT_YET_RECRUITING Santa Catarina Brazil Details
Biocon Investigational Site 1 NOT_YET_RECRUITING São Paulo Brazil Details
Biocon Investigational Site 2 NOT_YET_RECRUITING São Paulo Brazil Details
Biocon Investigational Site NOT_YET_RECRUITING São Paulo Brazil Details
Biocon Investigational Site NOT_YET_RECRUITING Providencia Chile Details
Biocon Investigational Site NOT_YET_RECRUITING Recoleta Chile Details
Biocon Investigational Site 1 NOT_YET_RECRUITING Santiago Chile Details
Biocon Investigational Site NOT_YET_RECRUITING Santiago Chile Details
Biocon Investigational Site NOT_YET_RECRUITING Batumi Georgia Details
Biocon Investigational Site NOT_YET_RECRUITING Kutaisi Georgia Details
Biocon Investigational Site 1 NOT_YET_RECRUITING Tbilisi Georgia Details
Biocon Investigational Site 3 NOT_YET_RECRUITING Tbilisi Georgia Details
Biocon Investigational Site 4 NOT_YET_RECRUITING Tbilisi Georgia Details
Biocon Investigational Site 5 NOT_YET_RECRUITING Tbilisi Georgia Details
Biocon Investigational Site NOT_YET_RECRUITING Tbilisi Georgia Details
Biocon Investigational Site NOT_YET_RECRUITING Chisinau Moldova Details
Biocon Investigational Site NOT_YET_RECRUITING Bucharest Romania Details
Site 26 NOT_YET_RECRUITING Cluj-Napoca Romania Details
Biocon Investigational Site NOT_YET_RECRUITING Craiova Romania Details
Biocon Investigational Site 1 RECRUITING Belgrade Serbia Details
Biocon Investigational Site NOT_YET_RECRUITING Belgrade Serbia Details
Biocon Investigational Site NOT_YET_RECRUITING Kamenitz Serbia Details
Biocon Investigational Site RECRUITING Kragujevac Serbia Details
Biocon Investigational Site NOT_YET_RECRUITING Niš Serbia Details
Biocon Investigational Site NOT_YET_RECRUITING George South Africa Details
Biocon Investigational Site 1 NOT_YET_RECRUITING Johannesburg South Africa Details
Biocon Investigational Site NOT_YET_RECRUITING Johannesburg South Africa Details
Biocon Investigational Site 1 NOT_YET_RECRUITING Barcelona Spain Details
Biocon Investigational Site NOT_YET_RECRUITING Barcelona Spain Details
Biocon Investigational Site NOT_YET_RECRUITING Madrid Spain Details
Biocon Investigational Site NOT_YET_RECRUITING Murcia Spain Details
Biocon Investigational Site NOT_YET_RECRUITING Sabadell Spain Details
Biocon Investigational Site 1 NOT_YET_RECRUITING Seville Spain Details
Biocon Investigational Site NOT_YET_RECRUITING Seville Spain Details
Biocon Investigational Site NOT_YET_RECRUITING Ankara Turkey (Türkiye) Details
Biocon Investigational Site NOT_YET_RECRUITING Bornova Turkey (Türkiye) Details
Biocon Investigational Site NOT_YET_RECRUITING Konak Turkey (Türkiye) Details
Biocon Investigational Site NOT_YET_RECRUITING Ivano-Frankivsk Ukraine Details
Biocon Investigational Site NOT_YET_RECRUITING Kyiv Ukraine Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field